Shenzhen Mindray (China) Performance
| 300760 Stock | 238.08 4.30 1.77% |
The entity has a beta of 0.0609, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Shenzhen Mindray's returns are expected to increase less than the market. However, during the bear market, the loss of holding Shenzhen Mindray is expected to be smaller as well. At this point, Shenzhen Mindray Bio has a negative expected return of -0.13%. Please make sure to validate Shenzhen Mindray's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Shenzhen Mindray Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Shenzhen Mindray Bio Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Forward Dividend Yield 0.0483 | Payout Ratio 0.9543 | Forward Dividend Rate 11.51 | Ex Dividend Date 2024-11-07 |
| Begin Period Cash Flow | 19 B |
Shenzhen |
Shenzhen Mindray Relative Risk vs. Return Landscape
If you would invest 25,879 in Shenzhen Mindray Bio Medical on December 29, 2024 and sell it today you would lose (2,071) from holding Shenzhen Mindray Bio Medical or give up 8.0% of portfolio value over 90 days. Shenzhen Mindray Bio Medical is generating negative expected returns and assumes 1.4683% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Shenzhen, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shenzhen Mindray Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shenzhen Mindray's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shenzhen Mindray Bio Medical, and traders can use it to determine the average amount a Shenzhen Mindray's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0907
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 300760 |
Estimated Market Risk
| 1.47 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Shenzhen Mindray is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shenzhen Mindray by adding Shenzhen Mindray to a well-diversified portfolio.
Shenzhen Mindray Fundamentals Growth
Shenzhen Stock prices reflect investors' perceptions of the future prospects and financial health of Shenzhen Mindray, and Shenzhen Mindray fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shenzhen Stock performance.
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.33 % | ||||
| Operating Margin | 0.43 % | ||||
| Current Valuation | 271.3 B | ||||
| Shares Outstanding | 1.21 B | ||||
| Price To Book | 7.78 X | ||||
| Price To Sales | 7.78 X | ||||
| Revenue | 34.93 B | ||||
| Gross Profit | 24.47 B | ||||
| EBITDA | 14.41 B | ||||
| Net Income | 11.58 B | ||||
| Total Debt | 7.75 M | ||||
| Book Value Per Share | 30.59 X | ||||
| Cash Flow From Operations | 11.06 B | ||||
| Earnings Per Share | 10.21 X | ||||
| Total Asset | 47.94 B | ||||
| Retained Earnings | 24.68 B | ||||
About Shenzhen Mindray Performance
By analyzing Shenzhen Mindray's fundamental ratios, stakeholders can gain valuable insights into Shenzhen Mindray's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shenzhen Mindray has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shenzhen Mindray has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shenzhen Mindray is entity of China. It is traded as Stock on SHE exchange.Things to note about Shenzhen Mindray Bio performance evaluation
Checking the ongoing alerts about Shenzhen Mindray for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shenzhen Mindray Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shenzhen Mindray Bio generated a negative expected return over the last 90 days | |
| Shenzhen Mindray Bio is unlikely to experience financial distress in the next 2 years | |
| About 57.0% of the company shares are owned by insiders or employees |
- Analyzing Shenzhen Mindray's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shenzhen Mindray's stock is overvalued or undervalued compared to its peers.
- Examining Shenzhen Mindray's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shenzhen Mindray's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shenzhen Mindray's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shenzhen Mindray's stock. These opinions can provide insight into Shenzhen Mindray's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Mindray's price analysis, check to measure Shenzhen Mindray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Mindray is operating at the current time. Most of Shenzhen Mindray's value examination focuses on studying past and present price action to predict the probability of Shenzhen Mindray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Mindray's price. Additionally, you may evaluate how the addition of Shenzhen Mindray to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |